- Catalogs
- CyberLogic
- UltraScan™ 650
UltraScan™ 650
UltraScan™ 650
The UltraScan™ 650 is a radiation-free alternative to DXA for measuring bone mineral density (BMD). It is the only FDA-approved bone sonometer for this purpose, developed by CyberLogic, Inc., a New York-based firm specializing in biomedical ultrasound.
Device Specifications
The UltraScan 650 is an ultrasound device designed to non-invasively assess bone density at the 1/3 location of the radius in the forearm. It estimates BMD in g/cm2 and provides a BMDUS Index, which correlates with DXA measurements. The device outputs T-scores and z-scores with a precision of 2.1%.
Technical Details
The BMDUS Index is highly correlated with DXA values, with a standard error of 0.041 g/cm2. It is expressed in grams/cm2 and as T- and z-scores, derived from a normative DXA reference database. The device is suitable for monitoring bone changes in postmenopausal women.
Indications for Use
The UltraScan 650 is portable, weighing 8 lbs and measuring 10x15 inches. It is USB-powered, requires no ionizing radiation or messy gel, and provides a ten-second test at a convenient forearm location. It estimates DXA BMD at the 1/3 radius with a correlation of r = 0.93.
Patents and Approvals
The device is protected by several U.S. and international patents and has received peer-reviewed funding from the NIH's SBIR program. FDA approval details can be found in the 510(k) summary.
Contact Information
For sales, marketing, or investment inquiries, contact Jonathan J. Kaufman, Ph.D., President & CEO of CyberLogic, Inc., at 611 Broadway, Suite 707, New York, NY 10012, or via email at [email protected].
Catalog excerpts
CONTACT For sales and marketing info, to place an order for an UltraScan 650, or to discuss potential investment and licensing, please contact: Jonathan J. Kaufman, Ph.D. President & CEO CyberLogic, Inc. 611 Broadway, Suite 707 New York, NY 10012 CYBERLOGIC®, INC. CyberLogic is a research and development firm in New York City (corner of Broadway and Houston Street, see image), founded in 1992. CyberLogic has been working in the field of biomedical ultrasound for over 20 years. 212-260-1351 (Voice) 212-260-1353 (Fax) [email protected] http://www.cyberlogic.org U.S. FDA approval (510(k) summary1) can be found at: https://www.accessdata.fda.g ov/cdrh_docs/pdf16/K161919. pdf The UltraScan 650 is protected by several U.S. and international patents, including U.S. Patent Nos. 7,862,510, 8,202,219, and 9,039,616, and China Patent No. ZL2008 1 0004839.7, among others. The UltraScan 650 has been developed with peer-reviewed funding from the Small Business Innovative Research (SBIR) program of the National Institutes of Health. The radiation-free alternative to DXA, with the only FDAapproved bone sonometer to measure bone mineral density (BMD).
Open the catalog to page 1
The UltraScan 650 • is an ultrasound device designed to non-invasively and quantitatively assess the amount of bone at the 1/3 location of the radius in the forearm of an individual. • is designed for the estimation of bone mineral density (BMD in g/cm2) of the radius at the 1/3 radius. • outputs a BMDus Index, an estimate of BMD that would be measured by DXA at the same anatomical location, that is, an estimate of BMDdxa, at the 1/3 radius. • outputs the T-score and z-score in standard deviations (SD). • has a precision of 2.1%. • Ten (10) second test • Convenient anatomical location (forearm) •...
Open the catalog to page 2Archived catalogs
Ultrasound Simulation in Bone14 Pages
